Tranont announced a telehealth partnership with BelleMD as the company steps into the GLP-1 space. Through this partnership, Tranont will now expand its wellness offerings to include provider-guided prescription weight-management and peptide therapies with science-backed nutritional support. The new wellness ecosystem will pair specialized nutrition support bundles with access to licensed health care providers – blending clinical innovation with traditional network marketing nutrition – and marking what the company calls a “major strategic pivot and milestone” in its 13-year history.
Through BelleMD, eligible individuals will have access to a secure telehealth platform where licensed healthcare providers can review personalized health information and prescribe GLP-1 therapies and other prescription peptides when appropriate.
“For more than a decade, we’ve empowered people to take control of their health through nutrition,” said Lorne Berry, Tranont Founder and CEO. “The BelleMD partnership represents one of the most significant milestones in Tranont’s history. By bringing together provider-guided care and science-backed nutritional support, we’re helping people build an even stronger foundation for long-term health.”
